check_circleStudy Completed

Magnetic Resonance Imaging

Bayer Identifier:

Trial_86144

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Gd-DTPA (SH L 451 AA) in MR tomography for the demonstration and demarcation of lesions in the region of the cranium and trunk

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

6 - 78 Years
  • -

  • -

Trial summary

Enrollment Goal
542
Trial Dates
June 1986 - July 1987
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Magnevist (Gadopentetate Dimeglumine, BAY86-4882)
Accepts Healthy Volunteer
N/A

Trial design

Tolerance and diagnostic quality of Gd-DTPA (SH L 451 AA) in MR tomography for the demonstration and demarcation of lesions in the region of the cranium and trunk
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.